Spencer C. Fleischer - 30 Dec 2022 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
Director
Signature
By Cheryl Brice, Attorney-in-Fact for
Issuer symbol
CLX
Transactions as of
30 Dec 2022
Transactions value $
$0
Form type
4
Filing time
04 Jan 2023, 16:09:37 UTC
Previous filing
23 Nov 2022
Next filing
27 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLX Deferred Stock Units Award $0 +94.6 +0.82% $0.00 11.6K 10 Nov 2022 Common Stock 94.6 Direct F1, F2, F3
transaction CLX Deferred Stock Units Award $0 +1.07K +9.22% $0.00 12.7K 30 Dec 2022 Common Stock 1.07K Direct F1, F3, F4
transaction CLX Deferred Stock Units Award $0 +219 +1.72% $0.00 12.9K 30 Dec 2022 Common Stock 219 Direct F1, F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1-for-1
F2 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F3 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F4 Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.
F5 Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.